The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid

Vanessa B. Vogensen; Richard M. Anthony; Huib A.M. Kerstjens; Simon Tiberi; Jurriaan E.M. de Steenwinkel; Onno W. Akkerman

doi:10.1016/j.cmi.2022.03.033

The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid

Vanessa B. Vogensen, Richard M. Anthony, Huib A.M. Kerstjens, Simon Tiberi, Jurriaan E.M. de Steenwinkel, Onno W. Akkerman^*

^*Corresponding author for this work

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1047-1049
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	28
Issue number	8
DOIs	https://doi.org/10.1016/j.cmi.2022.03.033
Publication status	Published - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2022.03.033

Cite this

@article{75962ec9c997412a9f039a490f27656f,

title = "The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid",

author = "Vogensen, {Vanessa B.} and Anthony, {Richard M.} and Kerstjens, {Huib A.M.} and Simon Tiberi and {de Steenwinkel}, {Jurriaan E.M.} and Akkerman, {Onno W.}",

year = "2022",

month = aug,

doi = "10.1016/j.cmi.2022.03.033",

language = "English",

volume = "28",

pages = "1047--1049",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid

AU - Vogensen, Vanessa B.

AU - Anthony, Richard M.

AU - Kerstjens, Huib A.M.

AU - Tiberi, Simon

AU - de Steenwinkel, Jurriaan E.M.

AU - Akkerman, Onno W.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85130852936&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2022.03.033

DO - 10.1016/j.cmi.2022.03.033

M3 - Comment/Letter to the editor

C2 - 35378271

AN - SCOPUS:85130852936

VL - 28

SP - 1047

EP - 1049

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 8

ER -

The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid

UN SDGs

Access to Document

Other files and links

Cite this